Prescription Drug Prices

WASHINGTON, D.C. — U.S. Senators Peter Welch (D-Vt.) and Jeff Merkley (D-Ore.) today introduced the bicameral 340B Pharmaceutical Access To Invest in Essential, Needed Treatments & Support (PATIENTS) Act, legislation that would protect the 340B drug pricing program and ensure patients—especially those in lower income…

Legislation would make it easier for generic and biosimilar drugs to enter the market, increasing competition and lowering the price of prescription drugs  WASHINGTON, D.C. – Today, U.S. Senators Peter Welch (D-Vt.), Josh Hawley (R-Mo.), and Amy Klobuchar (D-Minn.) teamed up to introduce the Eliminating Thickets…

WASHINGTON, D.C. – U.S. Senator Peter Welch (D-Vt.), a member of the Senate Finance Committee, today released the following statement on President Trump's Executive Order targeting the Medicare Drug Price Negotiation Program, a major long-term cost-saving feature of the Inflation Reduction Act which grants Medicare…

WASHINGTON, D.C. - U.S. Senators Peter Welch (D-Vt.), Amy Klobuchar (D-Minn.) and 23 of their Senate colleagues introduced legislation to boost Medicare negotiation of drug prices to lower prescription drug costs for consumers. The Strengthening Medicare and Reducing Taxpayer (SMART) Prices Act would give the Department…

WASHINGTON, D.C. – U.S. Senators Peter Welch (D-Vt.) and Roger Marshall (R-Kan.) announced the introduction of the Drug Price Transparency in Medicaid Act of 2023, legislation to limit abusive pricing practices by pharmacy benefit managers (PBMs), including the use of a technique called ‘spread pricing,’…